{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T20:57:50Z","timestamp":1792616270778,"version":"4.5.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T00:00:00Z","timestamp":1762819200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T00:00:00Z","timestamp":1762819200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-025-11986-0","type":"journal-article","created":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T21:57:46Z","timestamp":1762898266000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Efficacy of combination therapy with oral Ivermectin and topical permethrin versus permethrin monotherapy in pediatric patients with persistent scabies: a propensity score\u2013adjusted observational study"],"prefix":"10.1186","volume":"25","author":[{"given":"Zeliha","family":"Haytoglu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ozlem Ozgur","family":"Gundeslioglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bilge Fettahlioglu","family":"Karaman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,11]]},"reference":[{"issue":"12","key":"11986_CR1","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1016\/S1473-3099(17)30483-8","volume":"17","author":"C Karimkhani","year":"2017","unstructured":"Karimkhani C, Colombara DV, Drucker AM, Norton SA, Hay R, Engelman D, et al. The global burden of scabies: a cross-sectional analysis from the global burden of disease study 2015. Lancet Infect Dis. 2017;17(12):1247\u201354. https:\/\/doi.org\/10.1016\/S1473-3099(17)30483-8.","journal-title":"Lancet Infect Dis"},{"issue":"10","key":"11986_CR2","doi-asserted-by":"publisher","first-page":"e0139336","DOI":"10.1371\/journal.pone.0139336","volume":"10","author":"L Edison","year":"2015","unstructured":"Edison L, Beaudoin A, Goh L, Introcaso CE, Martin D, Dubray C, et al. Scabies and bacterial superinfection among American Samoan children, 2011\u20132012. PLoS ONE. 2015;10(10):e0139336. https:\/\/doi.org\/10.1371\/journal.pone.0139336.","journal-title":"PLoS ONE"},{"issue":"10","key":"11986_CR3","doi-asserted-by":"publisher","first-page":"e0009751","DOI":"10.1371\/journal.pntd.0009751","volume":"15","author":"P Gramp","year":"2021","unstructured":"Gramp P, Gramp D. Scabies in remote aboriginal and Torres Strait Islander populations in australia: a narrative review. PLoS Negl Trop Dis. 2021;15(10):e0009751. https:\/\/doi.org\/10.1371\/journal.pntd.0009751.","journal-title":"PLoS Negl Trop Dis"},{"key":"11986_CR4","unstructured":"Australian Institute of Health and Welfare (AIHW). Profile of Indigenous Australians. 2019. Available from: https:\/\/www.aihw.gov.au\/reports\/australias-welfare\/profile-of-indigenous-australians. Accessed 28 Jun 2023."},{"issue":"4","key":"11986_CR5","doi-asserted-by":"publisher","first-page":"235","DOI":"10.4274\/tpd.galenos.2023.50978","volume":"47","author":"P Etiz","year":"2023","unstructured":"Etiz P, Altunsu AT. The scabies epidemic during the COVID-19 pandemic. Turkiye Parazitol Derg. 2023;47(4):235\u20139. https:\/\/doi.org\/10.4274\/tpd.galenos.2023.50978.","journal-title":"Turkiye Parazitol Derg"},{"issue":"3","key":"11986_CR6","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1093\/infdis\/jiac507","volume":"225","author":"O Chosidow","year":"2022","unstructured":"Chosidow O, Giraudeau B, Badiaga S. Advances in scabies treatment and control. J Infect Dis. 2022;225(3):456\u201365. https:\/\/doi.org\/10.1093\/infdis\/jiac507.","journal-title":"J Infect Dis"},{"issue":"6","key":"11986_CR7","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1016\/j.jaad.2019.11.044","volume":"82","author":"G Yosipovitch","year":"2020","unstructured":"Yosipovitch G, Gupta AK, Srivastava M. Emerging treatments in scabies: an updated review. J Am Acad Dermatol. 2020;82(6):1437\u201345. https:\/\/doi.org\/10.1016\/j.jaad.2019.11.044.","journal-title":"J Am Acad Dermatol"},{"key":"11986_CR8","unstructured":"Turkish Pharmacists\u2019 Association. Overseas Drug Price List (EK-4\/C) \u2013 Stromectol\u00ae 3\u00a0mg \u00d7 20 tablets; retail price \u20ac 89.95. Issued 31 Jan 2019. Available from: https:\/\/www.teb.org.tr\/files\/ek4c_31012019.pdf. Accessed 15 Apr 2025."},{"key":"11986_CR9","unstructured":"Ministry of Labour and Social Security (T\u00fcrkiye). Net and Gross Minimum Wage by Years (1974\u20132024). Updated 1 Jul 2023. Available from: https:\/\/www.csgb.gov.tr\/media\/uygq4scn\/net-gross-minimum-wage-table.pdf. Accessed 15 Apr 2025."},{"key":"11986_CR10","unstructured":"Turkish Medicines and Medical Devices Agency. Human Medicinal Products Retail-Price List \u2013 Ziver\u00ae 3\u00a0mg film tablet, 10-tablet pack (\u20ba 591.18). List no. 2023\/03, published 28 Mar 2023. Available from: https:\/\/www.titck.gov.tr\/storage\/price_list_28032023.pdf. Accessed 15 Apr 2025."},{"key":"11986_CR11","unstructured":"Australian Government Department of Health and Aged Care. Schedule of Pharmaceutical Benefits \u2013 ivermectin 3\u00a0mg tablet, 4-tablet pack (PBS item 3546\u00a0N). Pharmaceutical Benefits Scheme. Jul 2024. Available from: https:\/\/www.pbs.gov.au\/medicine\/item\/3546N. Accessed 15 Apr 2025."},{"key":"11986_CR12","unstructured":"National Pharmaceutical Pricing Authority (India). Ceiling prices of scheduled formulations under DPCO-2013: ivermectin 3\u00a0mg tablet (notification S.O. 1235(E), 1 Apr 2024).Government of India. 2024. https:\/\/www.nppaindia.nic.in\/wpcontent\/uploads\/2024\/04\/so1235e_1apr2024.pdf. Accessed 15 Apr 2025."},{"issue":"2","key":"11986_CR13","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1128\/CMR.00042-06","volume":"20","author":"S Walton","year":"2007","unstructured":"Walton S, Currie BJ. Problems in diagnosing scabies, a global disease in human and animal populations. Clin Microbiol Rev. 2007;20(2):268\u201379. https:\/\/doi.org\/10.1128\/CMR.00042-06.","journal-title":"Clin Microbiol Rev"},{"issue":"4","key":"11986_CR14","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1111\/j.1469-0691.2012.03845.x","volume":"18","author":"RJ Hay","year":"2012","unstructured":"Hay RJ, Steer AC, Engelman D, Walton S. Scabies in the developing world \u2013 its prevalence, complications, and management. Clin Microbiol Infect. 2012;18(4):313\u201323. https:\/\/doi.org\/10.1111\/j.1469-0691.2012.03845.x.","journal-title":"Clin Microbiol Infect"},{"issue":"24","key":"11986_CR15","doi-asserted-by":"publisher","first-page":"2297","DOI":"10.1056\/NEJMoa0910031","volume":"362","author":"BJ Currie","year":"2010","unstructured":"Currie BJ, McCarthy JS. Permethrin and Ivermectin for scabies. N Engl J Med. 2010;362(24):2297\u2013306. https:\/\/doi.org\/10.1056\/NEJMoa0910031.","journal-title":"N Engl J Med"},{"issue":"3","key":"11986_CR16","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1080\/00273171.2011.568786","volume":"46","author":"PC Austin","year":"2011","unstructured":"Austin PC. An introduction to propensity score methods for reducing the effects of confounding in observational studies. Multivar Behav Res. 2011;46(3):399\u2013424. https:\/\/doi.org\/10.1080\/00273171.2011.568786.","journal-title":"Multivar Behav Res"},{"issue":"1","key":"11986_CR17","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1093\/biomet\/70.1.41","volume":"70","author":"PR Rosenbaum","year":"1983","unstructured":"Rosenbaum PR, Rubin DB. The central role of the propensity score in observational studies for causal effects. Biometrika. 1983;70(1):41\u201355. https:\/\/doi.org\/10.1093\/biomet\/70.1.41.","journal-title":"Biometrika"},{"issue":"3","key":"11986_CR18","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1111\/j.1742-7843.2009.00446.x","volume":"87","author":"B Vrijens","year":"2005","unstructured":"Vrijens B, Urquhart J. Methods for measuring, enhancing, and accounting for medication adherence in clinical trials. Clin Pharmacol Ther. 2005;87(3):402\u20136. https:\/\/doi.org\/10.1111\/j.1742-7843.2009.00446.x.","journal-title":"Clin Pharmacol Ther"},{"issue":"24","key":"11986_CR19","doi-asserted-by":"publisher","first-page":"2305","DOI":"10.1056\/NEJMoa1500987","volume":"373","author":"L Romani","year":"2015","unstructured":"Romani L, Whitfeld MJ, Koroivueta J, Kama M, Wand H, Tikoduadua L, et al. Mass drug administration for scabies control in a population with endemic disease. N Engl J Med. 2015;373(24):2305\u201313. https:\/\/doi.org\/10.1056\/NEJMoa1500987.","journal-title":"N Engl J Med"},{"issue":"5","key":"11986_CR20","doi-asserted-by":"publisher","first-page":"581","DOI":"10.4103\/0378-6323.84251","volume":"77","author":"R Sharma","year":"2011","unstructured":"Sharma R, Singal A. Topical permethrin and oral Ivermectin in the management of scabies: a prospective, randomized, double-blind, controlled study. Indian J Dermatol Venereol Leprol. 2011;77(5):581\u20136. https:\/\/doi.org\/10.4103\/0378-6323.84251.","journal-title":"Indian J Dermatol Venereol Leprol"},{"issue":"2 Pt 1","key":"11986_CR21","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1067\/mjd.2000.105349","volume":"42","author":"V Usha","year":"2000","unstructured":"Usha V, Nair T. A comparative study of oral Ivermectin and topical permethrin cream in the treatment of scabies. J Am Acad Dermatol. 2000;42(2 Pt 1):236\u201340. https:\/\/doi.org\/10.1067\/mjd.2000.105349.","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"11986_CR22","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1111\/j.1346-8138.2011.01481.x","volume":"39","author":"M Goldust","year":"2012","unstructured":"Goldust M, Rezaee E, Hemayat S. Treatment of scabies: comparison of permethrin 5% versus Ivermectin. J Dermatol. 2012;39(6):545\u20137. https:\/\/doi.org\/10.1111\/j.1346-8138.2011.01481.x.","journal-title":"J Dermatol"},{"issue":"1","key":"11986_CR23","doi-asserted-by":"publisher","first-page":"e87","DOI":"10.47750\/jptcp.2022.845","volume":"29","author":"S Dey","year":"2022","unstructured":"Dey S, Agarwal S, Sagar. Comparison of ivermectin, permethrin, and gamma benzene hexachloride alone and in combination for scabies management. J Popul Ther Clin Pharmacol. 2022;29(1):e87\u201396. https:\/\/doi.org\/10.47750\/jptcp.2022.845.","journal-title":"J Popul Ther Clin Pharmacol"},{"key":"11986_CR24","doi-asserted-by":"publisher","first-page":"101","DOI":"10.25258\/ijddt.13.1.15","volume":"13","author":"Z Al-Asadi","year":"2023","unstructured":"Al-Asadi Z, Al-Hamdi K, Ahmed J. Effectiveness of combined oral and topical Ivermectin compared to topical treatments in patients with scabies. Int J Drug Deliv Technol. 2023;13:101\u20134. https:\/\/doi.org\/10.25258\/ijddt.13.1.15.","journal-title":"Int J Drug Deliv Technol"},{"issue":"6","key":"11986_CR25","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1016\/j.jaad.2018.12.052","volume":"80","author":"K Thadanipon","year":"2019","unstructured":"Thadanipon K, Anothaisintawee T, Rattanasiri S, Thakkinstian A, Attia J. Efficacy and safety of antiscabietic agents: a systematic review and network meta-analysis of randomized controlled trials. J Am Acad Dermatol. 2019;80(6):1435\u201344. https:\/\/doi.org\/10.1016\/j.jaad.2018.12.052.","journal-title":"J Am Acad Dermatol"},{"key":"11986_CR26","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/j.fct.2018.12.013","volume":"125","author":"J Yang","year":"2019","unstructured":"Yang J, Qi W, Farias-Pereira R, Choi S, Clark J, Kim D, et al. Permethrin and Ivermectin modulate lipid metabolism in steatosis-induced HepG2 hepatocytes. Food Chem Toxicol. 2019;125:595\u2013604. https:\/\/doi.org\/10.1016\/j.fct.2018.12.013.","journal-title":"Food Chem Toxicol"},{"key":"11986_CR27","doi-asserted-by":"publisher","first-page":"110576","DOI":"10.1016\/j.fct.2019.110576","volume":"131","author":"W Qi","year":"2019","unstructured":"Qi W, Clark J, Suvorov A, Park Y. Ivermectin decreases triglyceride accumulation by inhibiting adipogenesis of 3T3-L1 preadipocytes. Food Chem Toxicol. 2019;131:110576. https:\/\/doi.org\/10.1016\/j.fct.2019.110576.","journal-title":"Food Chem Toxicol"},{"issue":"45","key":"11986_CR28","doi-asserted-by":"publisher","first-page":"757","DOI":"10.3238\/arztebl.2016.0757","volume":"113","author":"C Dressler","year":"2016","unstructured":"Dressler C, Rosumeck S, Sunderk\u00f6tter C, Werner R, Nast A. The treatment of scabies. Dtsch Arztebl Int. 2016;113(45):757\u201362. https:\/\/doi.org\/10.3238\/arztebl.2016.0757.","journal-title":"Dtsch Arztebl Int"},{"issue":"5","key":"11986_CR29","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1097\/00006454-199705000-00008","volume":"16","author":"JR Carapetis","year":"1997","unstructured":"Carapetis JR, Connors C, Yarmirr D, Krause V, Currie BJ. Success of a scabies control program in an Australian aboriginal community. Pediatr Infect Dis J. 1997;16(5):494\u20139. https:\/\/doi.org\/10.1097\/00006454-199705000-00008.","journal-title":"Pediatr Infect Dis J"},{"key":"11986_CR30","doi-asserted-by":"publisher","first-page":"100433","DOI":"10.1016\/j.lanwpc.2022.100433","volume":"22","author":"LJ Thean","year":"2022","unstructured":"Thean LJ, Romani L, Engelman D, Wand H, Jenney A, Mani J, et al. Prevention of bacterial complications of scabies using mass drug administration: a population-based, before-after trial in Fiji, 2018\u20132020. Lancet Reg Health West Pac. 2022;22:100433. https:\/\/doi.org\/10.1016\/j.lanwpc.2022.100433.","journal-title":"Lancet Reg Health West Pac"},{"key":"11986_CR31","doi-asserted-by":"publisher","first-page":"28","DOI":"10.12703\/r\/10-28","volume":"10","author":"E Welch","year":"2021","unstructured":"Welch E, Romani L, Whitfeld MJ. Recent advances in Understanding and treating scabies. Fac Rev. 2021;10:28. https:\/\/doi.org\/10.12703\/r\/10-28.","journal-title":"Fac Rev"},{"issue":"08","key":"11986_CR32","doi-asserted-by":"publisher","first-page":"7474","DOI":"10.29309\/tpmj\/2023.30.08.7474","volume":"30","author":"S Goraya","year":"2023","unstructured":"Goraya S, Aamir S, Bajwa B, Rahat B, Afzal T, Naseem R. Efficacy and safety of oral Ivermectin combined with topical permethrin in the treatment of scabies. Prof Med J. 2023;30(08):7474. https:\/\/doi.org\/10.29309\/tpmj\/2023.30.08.7474.","journal-title":"Prof Med J"},{"issue":"4","key":"11986_CR33","doi-asserted-by":"publisher","first-page":"CD012994","DOI":"10.1002\/14651858.CD012994","volume":"4","author":"S Rosumeck","year":"2018","unstructured":"Rosumeck S, Nast A, Dressler C. Ivermectin and permethrin for treating scabies. Cochrane Database Syst Rev. 2018;4(4):CD012994. https:\/\/doi.org\/10.1002\/14651858.CD012994.","journal-title":"Cochrane Database Syst Rev"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-11986-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-025-11986-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-11986-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T21:57:57Z","timestamp":1762898277000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-025-11986-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,11]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["11986"],"URL":"https:\/\/doi.org\/10.1186\/s12879-025-11986-0","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,11]]},"assertion":[{"value":"21 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol received approval from the Cukurova University Ethics Committee (Approval No: 145\/14062024) and adhered to the principles of the Declaration of Helsinki. Written informed consent was obtained from a parent or legal guardian for every participating child.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1545"}}